MAM
Redcliffe Life Diagnostics onboards Milind Soman as brand ambassador
New Delhi: Redcliffe Life Diagnostics on Tuesday announced Milind Soman as its brand ambassador. The association aims at creating awareness among people regarding the importance of health check-ups for the timely diagnosis and treatment of ailments.
A pioneer in gene-based testing in the country, Redcliffe Life Diagnostics has been pushing preventive healthcare and early diagnosis of diseases. “Having Milind onboard will help in reaching wider audiences to create awareness about public health in general,” it said on Tuesday.
Redcliffe Life Diagnostics’ founder, Dheeraj Jain said, “We are delighted to have Milind Soman on board. He is a true ambassador and advocate of healthy living. He can be a great stimulus to encourage people to get routine health check-ups done regularly. Covid-19 has exponentially pushed health consciousness, but still, there is an aversion towards getting tested. People associate getting tested with being ill or sick, and this is the myth we want to break with Milind on board.”
Milind Soman said he is looking forward to the collaboration. “Regular health check-ups can help in the early diagnosis of the disease. It is great to see how the medical industry is changing with organized and professional corporates like Redcliffe advocating profusely about preventive healthcare in India. Seeing their affordable yet advanced health packages from blood-based tests to fitness/wellness genetic testing, I am sure more people will be encouraged to be proactive towards health checkups,” he said.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
